Creative Planning 23and Me Holding Co. Transaction History

Creative Planning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$0.29 - $0.51 $89 - $157	-308 Reduced 0.88%	34,771 $12,000
Q2 2024 Aug 15, 2024	BUY	$0.36 - $0.61 $110 - $187	308 Added 0.89%	35,079 $13,000
Q1 2024 May 10, 2024	SELL	$0.4 - $0.91 $499 - $1,135	-1,248 Reduced 3.46%	34,771 $18,000
Q4 2023 Feb 14, 2024	SELL	$0.71 - $0.97 $6,875 - $9,393	-9,684 Reduced 21.19%	36,019 $32,000
Q3 2023 Nov 16, 2023	BUY	$0.96 - $2.01 $9,030 - $18,908	9,407 Added 25.92%	45,703 $44,000
Q2 2023 Jul 21, 2023	SELL	$1.59 - $2.29 $127 - $183	-80 Reduced 0.22%	36,296 $63,000
Q1 2023 May 15, 2023	BUY	$2.05 - $2.87 $164 - $229	80 Added 0.22%	36,376 $82,000
Q4 2022 Feb 10, 2023	BUY	$2.06 - $3.47 $74,769 - $125,947	36,296 New	36,296 $78,000

8.42M

50K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $387M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.